News from Brown Technology Innovations:
Brown Technology Innovations- Our name change is official!
May, 2020. We have officially changed our name to Brown Technology Innovations. You formerly knew us as the Office of Industry Engagement and Commercial Venturing, and some may recall the predecessor of IECV, known as the Tech Ventures Office (T-VO). Under new leadership from Neil Veloso but with the same staff, our team will pursue a new strategy to bring inventions from Brown research teams to have an impact through commercial channels. More about us: new strategy, same team.
COVID-19 Clinical Trial Industry Contract
May, 2020. BTI executed a contract with an industry sponsor for a clinical trial to be overseen by Dr. Stefan Gravenstein, Professor of Medicine and Director, Division of Geriatrics and Palliative Care. The trial is a randomized, double-blind, placebo-controlled study to evaluate whether prophylaxis with the industry sponsor’s therapeutic compound reduces the incidence of COVID-19 among residents of nursing home facilities. The name of the company is being kept confidential for now.
Brown Technology Innovations at BIO 2020...Online
May, 2020. Brown Technology Innovations, the commercialization arm of the university, will showcase several life science inventions from Brown at the 2020 Biotechnology Industry Organization conference (BIO). Normally one of the largest fixtures of the life sciences international conference trail each year, this year’s event will be online. BIO will feature partnering/networking opportunities for Brown to connect with potential investors and collaborators from life science and pharma companies. Please contact Betsy Stubblefield Loucks and David Potter if you have interesting news or company connections related to BIO 2020. https://www.bio.org/events/bio-digital
Creating Quantum Safe Signatures
Cheaper and Better: Invention of an Industrial 3-D Scanner
Dr. Taubin’s breakthrough means that scans could be done using commercially available hardware that is much less expensive than current best practices.
This month, Brown was issued a patent for Dr. Taubin’s work. The intellectual property in the patent has been licensed to an early stage startup called Riven, who raised $2 million in seed capital last year, and is on track to raise $10 million this year to get to the next stage.
Dr. Taubin’s current research projects emphasize low cost precise 3D scanning systems, 3D scanning for 3D printing, industrial applications of 3D scanning systems, and more generally digital fabrication.
The Patent Parade Continues
Orsted, a Danish renewable energy company, is visiting Brown with CommerceRI. IECV also hosted the VP of Future Technology from Hyundai Motor Company (Seoul, Korea) to visit researchers and students that they are currently funding ($50K each): Kenny Breuer/Sharon Swartz (collaborative), David Sheinberg, William Warren and Stefanie Tellex.
Brown’s relationship with Hyundai Motor Group is quickly becoming a model for University-Industry partnerships that deepen understandings between scientists, and expands Hyundai’s investment in Brown over time. We completed the Hyundai Visionary Challenge last fall, and have funded four pilot research projects ($50,000) for Drs. Kenny Breuer and Sharon Swartz, David Sheinberg, Stefanie Tellex and William Warren. These teams will present at the Hyundai Mobility Innovator’s Forum in San Francisco in November. The next phase will be announced later this fall (roughly $200,000 for four projects for 1 year, with potential for additional year).
The Brown Biomedical Idea to Impact fund, run by Karen Bulock, announced five awards ($100,000 each) for biomedical innovations originating at Brown this past July. A new cycle will start this fall. BBII will host the Boston Biomedical Innovation Center (B-BIC), an NHLBI funded accelerator, to give three half-day workshops on Pitching, Slide Design, and Healthcare Market Research on October 11, 15, and 16 at Brown. Contact Karen for more information.
The mission of Brown Technology Innovations is to put Brown University’s technology first to drive commercial outcomes that benefit the University and society.
With its responsibilities to manage the university’s patent portfolio, the Brown University technology transfer office, called Brown Technology Innovations is first and foremost focused on commercialization.
We serve two customers: the faculty members who provide invention disclosures for patenting and commercialization; and the investors, entrepreneurs and companies that develop university technology. The faculty customer engages with our office concerning technology – specifically the evaluation of invention disclosures, the technology’s patenting and its licensing. The technology investor customer works with our office because they wish to obtain or support technology.
For Brown Technology Innovations, our focus is on Technology First. Read our full strategy here.
Over the coming the months, our office will be adding more resources and content to these pages. In the meantime, we want to hear from you. Please contact our team.